Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-01

Clinical Trial Update: Ramelteon Prevention of Delirium - RCT [Phase 4]

View source ↗

Summary

Phase 4 randomized trial investigating ramelteon for prevention of delirium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

Sponsor: Hartford Hospital | Conditions: Delirium | Phase 4 | Status: UNKNOWN